Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 7887 EAST BELLEVIEW AVENUE, SUITE 500 GREENWOOD VILLAGE CO 80111 |
Tel: | 1-720-2873093 |
Website: | N/A |
IR: | N/A |
Key People | ||
John Allen Farlinger Executive Chairman of the Board, Chief Executive Officer | Paul Webster Interim Chief Financial Officer |
Business Overview |
Assure Holdings Corp. is a provider of outsourced intraoperative neurophysiological monitoring (IONM) and remote neurology services. The Company delivers a suite of clinical and operational services to support surgeons and medical facilities during invasive procedures. Its IONM tool is used for various surgical verticals, such as neurosurgery, spine, ear, nose, and throat, and other surgical procedures. Its in-house interoperative neurophysiologists (INP) provide the technical component IONM services from the operating room throughout the procedure, while telehealth-oriented supervising practitioners provide a level of redundancy and risk mitigation in support of the onsite INPs and the surgical team. It offers IONM services, including scheduling the INP and supervising practitioner, real-time monitoring, patient advocacy and subsequent billing for services provided. During each procedure, it provides two types of services, the Technical Component and Professional Component of IONM. |
Financial Overview |
For the fiscal year ended 31 December 2023, Assure Holdings Corp revenues decreased 46% to $255K. Net loss before extraordinary items decreased 6% to $21.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Impairment Charges decrease from $3.4M (expense) to $0K, General and administrative decrease of 10% to $13.5M (expense). |
Employees: | 95 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $18.83M as of Dec 31, 2023 |
Annual revenue (TTM): | $0.26M as of Dec 31, 2023 |
EBITDA (TTM): | -$15.35M as of Dec 31, 2023 |
Net annual income (TTM): | -$21.45M as of Dec 31, 2023 |
Free cash flow (TTM): | -$5.04M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $14.55M as of Dec 31, 2023 |
Shares outstanding: | 9,000,000 as of Apr 24, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |